SLEE medical (Germany) was founded in London in 1954 and it released its first model of freezing microtome the same year.
Now SLEE medical is one of the world leaders in manufacturing equipment for preanalytical stage of microscopy and provision of pathological and histology laboratories.
More than 50 years SLEE medical develops, improves and prepares cryostats, microtomes, equipment for filling and painting specimen, smoothing sections and many others what is necessary for daily work of histology laboratory.
Combining flexible approach with highest qualifications of company specialists enables to work with individual orders and satisfy any technical needs of users. Slee Medical is one of the leading manufacturers of histological equipment and vacuum and carousel-type histological processors from Germany.
Elisabeth Pharmacon Ltd. was founded by Czech biologist Dr. Omar Sery and businessman Petr Cermak in London (2012). Company sells DNA diagnostics under EliGene® brand name and PCR workstation under brand name Zephyrus.
Elisabeth Pharmacon Ltd. is the member of the international group Elisabeth Pharmacon Group. Elisabeth Pharmacon spol. s.r.o. headquartered in the Czech Republic is also its member.
This company cooperates with many scientific research institutes and clinics. From the moment of its foundation the Czech company cooperated with the Faculty of Science of Masaryk University. It became the first Czech company producing DNA diagnostics according to EN ISO 13485:2012 certificate in 2008. Systems of quality EN ISO 13485:2003 and EN ISO 9001:2008 cover all types of activities such as project development, development, production, purchase, storage and sales of medical devices and medical tools for in vitro diagnostics and molecular-biological trials, measurement and analysis. The aim is to offer product of the highest quality at the best affordable price in the market.
HLA-B27 is the main immunogenetic marker of high predisposition to development of ankylosing spondylitis (Bekhterev’s disease) and other related seronegative spondyloarthropathies.